Leaflet CICLOSERINA ATB 250mg capsules


Indicated for: tuberculosis

Route of administration: oral

Substance: cycloserine (anti-tuberculosis agent)

ATC: J04AB01 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics)

Cycloserine is an antibiotic used in the treatment of drug-resistant tuberculosis and urinary tract infections caused by susceptible bacteria. It works by inhibiting bacterial cell wall synthesis, leading to bacterial destruction.

The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's weight and the severity of the infection. Common side effects include dizziness, headaches, irritability, and insomnia.

Cycloserine is contraindicated in patients with severe renal impairment or severe psychiatric disorders. Its use also requires careful monitoring to prevent neurological toxicity.

This medication is an important option for treating resistant bacterial infections, helping to improve the prognosis of affected patients.

General data about CICLOSERINA ATB 250mg

  • Substance: cycloserine
  • Date of last drug list: 01-05-2026
  • Commercial code: W52079002
  • Concentration: 250mg
  • Pharmaceutical form: capsules
  • Quantity: 100
  • Product type: generic
  • Price: 832.89 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 10903/18/02
  • Shelf life: 3 years

Compensation lists for CICLOSERINA ATB 250mg Antibiotice

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

832.89 RON

832.89 RON

0.00 RON